UF researchers identify potential new therapeutic target in T-cell lymphomas
The findings open the door to developing a new drug treatment that targets the gene.
All Posts by
The findings open the door to developing a new drug treatment that targets the gene.
The findings, presented at the American Society of Hematology 67th Annual Meeting and Exposition in Orlando on Sunday, give researchers a target for developing a new treatment to restore the health of blood stem cells and improve recovery from cancer treatments.
Thomas George, M.D., FACP, FASCO, was interviewed by AAMC News on how GLP-1 medications affect cancer risk and mortality.
After further study to confirm safety, the team hopes to achieve FDA approval.
The council creates and approves a program for cancer control and research in the state.
The UF Health Cancer Institute will be presenting at the ASH 67th Annual Meeting and Exposition in Florida.
The Cancer AI Symposium explored how AI is transforming the way cancer is studied, diagnosed and treated.
Multidisciplinary collaboration is transforming the landscape of thyroid cancer care.
October UF Health Cancer Institute publications.
Naomi Parker studies how to make cancer clinical trials more accessible.